BML Capital Management »

Achilles Therapeutics shares owned by BML Capital Management

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by BML Capital Management from 13F filings

Historical chart of BML Capital Management investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by BML Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by BML Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $510k 625k 0.82

More positions owned by BML Capital Management

Ishares Tr 0-3 Mnth Treasry (SGOV)
Atea Pharmaceuticals (AVIR)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Aclaris Therapeutics (ACRS)
Adverum Biotechnologies Com New (ADVM)
Tectonic Therapeutic (TECX)
Reneo Pharmaceuticals (RPHM)
Instil Bio Com New (TIL)
Wingstop Put Option (WING)
Oramed Pharmaceuticals Com New (ORMP)
Connect Biopharma Hldgs Ads (CNTB)
Athira Pharma (ATHA)
Vanda Pharmaceuticals (VNDA)
Pmv Pharmaceuticals (PMVP)
Astrotech Corp (ASTC)

View all positions for BML Capital Management

Top funds holding Achilles Therapeutics

Syncona Portfolio
Fcpm Iii Services B.v.
Redmile Group
Vestal Point Capital
Ikarian Capital
Baker Bros. Advisors
Artal Group
Renaissance Technologies
BML Capital Management
Acadian Asset Management
Citadel Advisors
XTX Topco
Two Sigma Advisers
Virtu Financial
Geode Capital Management

View all funds holding Achilles Therapeutics